Molecular Targets for Nutrients in Prostate Cancer Prevention

The summary for the Molecular Targets for Nutrients in Prostate Cancer Prevention grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Molecular Targets for Nutrients in Prostate Cancer Prevention: The Division of Cancer Prevention, National Cancer Institute (NCI), invites applications for new R01 grants to foster probing investigations that will define molecular targets for nutrients and further, connect those targets with phenotypic outcome in prostate cancer prevention. Candidate targets for examination should not only be influenced by a nutrient but also be closely linked to a significant proportion of prostate tumors, be relatively specific for prostate cancer across various genetic backgrounds, and be related to changes in tumor risk and/or behavior when modified. Investigators are encouraged to use in vitro and in vivo studies with various levels of target expression and to address confounding factors that influence the overall physiological response to changes in a given molecular target.
Federal Grant Title: Molecular Targets for Nutrients in Prostate Cancer Prevention
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-04-004
Type of Funding: Grant
CFDA Numbers: 93.393
CFDA Descriptions: Cancer Cause and Prevention Research
Current Application Deadline: No deadline provided
Original Application Deadline: Jul 17, 2003
Posted Date: Aug 04, 2003
Creation Date: Aug 16, 2003
Archive Date: Aug 16, 2003
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email [email protected] [email protected] Webmaster, NIH
Similar Government Grants
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer ...
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Cli...
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U0...
Pilot Studies in Pancreatic Cancer
Cancer Prevention Research Small Grant Program
Cancer Prevention Research Small Grant Program (R03)
More Grants from the National Institutes of Health
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required...
NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 -...
HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed)
Single Source: NINDS Exploratory Clinical Trials (U01 Clinical Trial Required)
Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com